{"organizations": [], "uuid": "35314908de104a96bf1504c44a5bafe358c5c78e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-catalyst-biosciences-receives-15-m/brief-catalyst-biosciences-receives-1-5-million-for-neuronal-nicotinic-receptor-asset-idUSASC09TL7", "country": "US", "domain_rank": 408, "title": "BRIEF-Catalyst Biosciences Receives $1.5 Million For Neuronal Nicotinic Receptor Asset", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-26T15:13:00.000+03:00", "replies_count": 0, "uuid": "35314908de104a96bf1504c44a5bafe358c5c78e"}, "author": "", "url": "https://www.reuters.com/article/brief-catalyst-biosciences-receives-15-m/brief-catalyst-biosciences-receives-1-5-million-for-neuronal-nicotinic-receptor-asset-idUSASC09TL7", "ord_in_thread": 0, "title": "BRIEF-Catalyst Biosciences Receives $1.5 Million For Neuronal Nicotinic Receptor Asset", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-catalyst biosciences", "sentiment": "negative"}, {"name": "catalyst biosciences inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "neuronal nicotinic receptor asset reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 26, 2018 / 12:16 PM / Updated 5 minutes ago BRIEF-Catalyst Biosciences Receives $1.5 Million For Neuronal Nicotinic Receptor Asset Reuters Staff 1 Min Read March 26 (Reuters) - Catalyst Biosciences Inc: * CATALYST BIOSCIENCES RECEIVES $1.5 MILLION IN TWO MILESTONE PAYMENTS FOR NEURONAL NICOTINIC RECEPTOR (NNR) ASSET Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-26T15:13:00.000+03:00", "crawled": "2018-03-26T15:26:33.014+03:00", "highlightTitle": ""}